| A Study to Assess Vamorolone in Becker Muscular Dystrophy (BMD) (NCT05166109) | ReveraGen BioPharma, Inc. | 2022-07-07 |
| Schulze Muscular Dystrophy Ability Clinical Study (NCT05409079) | AbiliTech Medical Inc. | 2022-05-26 |
| Defining Endpoints in Becker Muscular Dystrophy (NCT05257473) | Virginia Commonwealth University | 2022-04-13 |
| A Study of EDG-5506 in Adult Males With Becker Muscular Dystrophy (NCT05160415) | Edgewise Therapeutics, Inc. | 2021-12-28 |
| Brain Involvement in Dystrophinopathies Part 2 (NCT04668716) | Great Ormond Street Hospital for Children NHS Foundation Trust | 2021-10-11 |
| CureDuchenne Link®: A Resource for Research (NCT04972604) | CureDuchenne | 2021-07-09 |
| Brain Involvement in Dystrophinopathies Part 1 (NCT04583917) | Great Ormond Street Hospital for Children NHS Foundation Trust | 2021-03-30 |
| Magnetic Resonance Imaging and Biomarkers for Muscular Dystrophy (NCT01484678) | University of Florida | 2020-09-01 |
| Safety and Biomarker Response to (+)-Epicatechin in Becker Muscular Dystrophy (NCT04386304) | Epirium Bio Inc. | 2020-07-13 |
| Fast Troponin as a Biomarker to Assess Exercise-induced Muscle Damage in Muscle Diseases (NCT04349566) | Mads Peter Godtfeldt Stemmerik | 2020-06-01 |
| Weekly Steroids in Muscular Dystrophy (NCT04054375) | Northwestern University | 2019-07-01 |
| UTSW HP [13-C] Pyruvate Injection in HCM (NCT03057002) | University of Texas Southwestern Medical Center | 2018-05-01 |
| Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Becker Muscular Dystrophy (NCT03238235) | Italfarmaco | 2018-01-09 |
| (-)- Epicatechin Becker Muscular Dystrophy (NCT03236662) | Craig McDonald, MD | 2016-11-01 |
| Characterization of Clinical Skeletal and Cardiac Impairment in Carriers of DMD and BMD (NCT02972580) | Nationwide Children's Hospital | 2016-06-01 |
| Sodium Nitrate for Muscular Dystrophy (NCT02434627) | Cedars-Sinai Medical Center | 2015-06-01 |
| Biomarker Development for Muscular Dystrophies (NCT05019625) | Massachusetts General Hospital | 2015-02-20 |
| Muscle MRI in Becker Muscular Dystrophy and in Limb-girdle Muscular Dystrophy Type 2I (NCT02165358) | Rigshospitalet, Denmark | 2014-06-01 |
| Evaluation of Muscle miRNA as Biomarkers in Dystrophinopathies (NCT02109692) | University Hospital, Montpellier | 2014-05-19 |
| Effects of Sodium Nitrate on Blood Flow in Becker Muscular Dystrophy (NCT02147639) | Cedars-Sinai Medical Center | 2013-10-01 |
| Sodium Nitrate to Improve Blood Flow (NCT02847975) | Cedars-Sinai Medical Center | 2013-10-01 |
| Use of (-)-Epicatechin in the Treatment of Becker Muscular Dystrophy (Pilot Study) (NCT01856868) | Craig McDonald, MD | 2013-05-01 |
| Study of Ataluren for Previously Treated Participants With Nonsense Mutation Duchenne/Becker Muscular Dystrophy (nmDBMD) in Europe, Israel, Australia, and Canada (NCT01557400) | PTC Therapeutics | 2012-05-20 |
| Becker Muscular Dystrophy - A Natural History Study to Predict Efficacy of Exon Skipping (NCT01539772) | Cooperative International Neuromuscular Research Group | 2012-04-01 |
| Effect of Modulating the nNOS System on Cardiac, Muscular and Cognitive Function in Becker Muscular Dystrophy Patients (NCT01350154) | Rigshospitalet, Denmark | 2011-11-01 |
| Revatio for Heart Disease in Duchenne Muscular Dystrophy and Becker Muscular Dystrophy (NCT01168908) | Hugo W. Moser Research Institute at Kennedy Krieger, Inc. | 2010-09-01 |
| Cardiac Magnetic Resonance in Children With Muscular Dystrophy (NCT01081080) | Cooperative International Neuromuscular Research Group | 2010-04-01 |
| Clinical Trial of Coenzyme Q10 and Lisinopril in Muscular Dystrophies (NCT01126697) | Cooperative International Neuromuscular Research Group | 2010-02-01 |
| Study of Ataluren (PTC124) in Nonambulatory Participants With Nonsense-Mutation-Mediated Duchenne/Becker Muscular Dystrophy (nmDMD/BMD) (NCT01009294) | PTC Therapeutics | 2010-01-13 |
| Cardiac Outcome Measures in Children With Muscular Dystrophy (NCT01066455) | Cooperative International Neuromuscular Research Group | 2010-01-01 |
| Evaluation of Limb-Girdle Muscular Dystrophy (NCT00893334) | Cooperative International Neuromuscular Research Group | 2009-04-01 |
| Safety Study of Transvenous Limb Perfusion in Human Muscular Dystrophy (NCT00873782) | University of North Carolina, Chapel Hill | 2009-03-01 |
| Phase 2B Extension Study of Ataluren (PTC124) in Duchenne/Becker Muscular Dystrophy (DMD/BMD) (NCT00847379) | PTC Therapeutics | 2009-01-31 |
| Ramipril Versus Carvedilol in Duchenne and Becker Patients (NCT00819845) | Catholic University, Italy | 2008-12-01 |
| Study Evaluating MYO-029 in Adult Muscular Dystrophy (NCT00104078) | Wyeth is now a wholly owned subsidiary of Pfizer | 2005-02-01 |
| Gentamicin Treatment of Muscular Dystrophy (NCT00005574) | National Institute of Neurological Disorders and Stroke (NINDS) | 2000-02-01 |
| CRD007 for the Treatment of Duchenne Muscular Dystrophy, Becker Muscular Dystrophy and Symptomatic Carriers (NCT01540604) | RSPR Pharma AB | |